カテゴリ： 世界, 医療/バイオ, QYResearch

セザリー症候群治療の世界市場2023年：放射線療法、化学療法、免疫療法、体外光化学療法

■ 英語タイトル：Global Sezary Syndrome Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA6930）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA6930
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[セザリー症候群治療の世界市場2023年：放射線療法、化学療法、免疫療法、体外光化学療法]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はセザリー症候群治療のグローバル市場について調査・分析し、世界のセザリー症候群治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（放射線療法、化学療法、免疫療法、体外光化学療法）、用途別セグメント分析（病院、専門クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Innate Pharma、Kyowa Kirin、Shionogi、Bioniz Therapeutics、Eisai、Bayer、Minophagen Pharmaceutical Co., Ltd、Novartis、STI Pharma、Gilead、Merck、Hikma、Seattle Genetics、Amerigen Pharmaceuticalsなどが含まれています。セザリー症候群治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、セザリー症候群治療市場規模を算出する際に考慮しました。

・セザリー症候群治療市場の概要
- セザリー症候群治療の種類別セグメント
- 世界のセザリー症候群治療市場規模：タイプ別分析（放射線療法、化学療法、免疫療法、体外光化学療法）
- セザリー症候群治療の用途別セグメント
- 世界のセザリー症候群治療市場規模：用途別分析（病院、専門クリニック、その他）
- 世界のセザリー症候群治療市場規模予測（2018年-2029年）

・セザリー症候群治療市場の成長トレンド
- セザリー症候群治療の地域別市場規模（2018年-2029年）
- セザリー症候群治療市場ダイナミクス
- セザリー症候群治療の業界動向
- セザリー症候群治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：放射線療法、化学療法、免疫療法、体外光化学療法
- 世界のセザリー症候群治療のタイプ別市場規模（2018年-2023年）
- 世界のセザリー症候群治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、専門クリニック、その他
- 世界のセザリー症候群治療の用途別市場規模（2018年-2023年）
- 世界のセザリー症候群治療の用途別市場規模（2024年-2029年）

・セザリー症候群治療の地域別市場規模
- 北米のセザリー症候群治療市場規模（2018年-2029年）
- 米国のセザリー症候群治療市場規模（2018年-2029年）
- ヨーロッパのセザリー症候群治療市場規模（2018年-2029年）
- アジア太平洋のセザリー症候群治療市場規模（2018年-2029年）
- 中国のセザリー症候群治療市場規模（2018年-2029年）
- 日本のセザリー症候群治療市場規模（2018年-2029年）
- 韓国のセザリー症候群治療市場規模（2018年-2029年）
- インドのセザリー症候群治療市場規模（2018年-2029年）
- オーストラリアのセザリー症候群治療市場規模（2018年-2029年）
- 中南米のセザリー症候群治療市場規模（2018年-2029年）
- 中東・アフリカのセザリー症候群治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Innate Pharma、Kyowa Kirin、Shionogi、Bioniz Therapeutics、Eisai、Bayer、Minophagen Pharmaceutical Co., Ltd、Novartis、STI Pharma、Gilead、Merck、Hikma、Seattle Genetics、Amerigen Pharmaceuticals

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Sezary Syndrome Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Sezary Syndrome Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Sezary Syndrome Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Sezary Syndrome Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Sezary Syndrome Treatment include Innate Pharma, Kyowa Kirin, Shionogi, Bioniz Therapeutics, Eisai, Bayer, Minophagen Pharmaceutical Co., Ltd, Novartis and STI Pharma, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sezary Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sezary Syndrome Treatment.
The Sezary Syndrome Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Sezary Syndrome Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sezary Syndrome Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Innate Pharma
Kyowa Kirin
Shionogi
Bioniz Therapeutics
Eisai
Bayer
Minophagen Pharmaceutical Co., Ltd
Novartis
STI Pharma
Gilead
Merck
Hikma
Seattle Genetics
Amerigen Pharmaceuticals
Segment by Type
Radiation therapy
Chemotherapy
Immunotherapy
Extracorporeal Photochemotherapy
Segment by Application
Hospital
Specialist Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sezary Syndrome Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sezary Syndrome Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Radiation therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Extracorporeal Photochemotherapy
1.3 Market by Application
1.3.1 Global Sezary Syndrome Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sezary Syndrome Treatment Market Perspective (2018-2029)
2.2 Sezary Syndrome Treatment Growth Trends by Region
2.2.1 Global Sezary Syndrome Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Sezary Syndrome Treatment Historic Market Size by Region (2018-2023)
2.2.3 Sezary Syndrome Treatment Forecasted Market Size by Region (2024-2029)
2.3 Sezary Syndrome Treatment Market Dynamics
2.3.1 Sezary Syndrome Treatment Industry Trends
2.3.2 Sezary Syndrome Treatment Market Drivers
2.3.3 Sezary Syndrome Treatment Market Challenges
2.3.4 Sezary Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sezary Syndrome Treatment Players by Revenue
3.1.1 Global Top Sezary Syndrome Treatment Players by Revenue (2018-2023)
3.1.2 Global Sezary Syndrome Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Sezary Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sezary Syndrome Treatment Revenue
3.4 Global Sezary Syndrome Treatment Market Concentration Ratio
3.4.1 Global Sezary Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sezary Syndrome Treatment Revenue in 2022
3.5 Sezary Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Sezary Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Sezary Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sezary Syndrome Treatment Breakdown Data by Type
4.1 Global Sezary Syndrome Treatment Historic Market Size by Type (2018-2023)
4.2 Global Sezary Syndrome Treatment Forecasted Market Size by Type (2024-2029)
5 Sezary Syndrome Treatment Breakdown Data by Application
5.1 Global Sezary Syndrome Treatment Historic Market Size by Application (2018-2023)
5.2 Global Sezary Syndrome Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Sezary Syndrome Treatment Market Size (2018-2029)
6.2 North America Sezary Syndrome Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Sezary Syndrome Treatment Market Size by Country (2018-2023)
6.4 North America Sezary Syndrome Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sezary Syndrome Treatment Market Size (2018-2029)
7.2 Europe Sezary Syndrome Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Sezary Syndrome Treatment Market Size by Country (2018-2023)
7.4 Europe Sezary Syndrome Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sezary Syndrome Treatment Market Size (2018-2029)
8.2 Asia-Pacific Sezary Syndrome Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Sezary Syndrome Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Sezary Syndrome Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sezary Syndrome Treatment Market Size (2018-2029)
9.2 Latin America Sezary Syndrome Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Sezary Syndrome Treatment Market Size by Country (2018-2023)
9.4 Latin America Sezary Syndrome Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sezary Syndrome Treatment Market Size (2018-2029)
10.2 Middle East & Africa Sezary Syndrome Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Sezary Syndrome Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Sezary Syndrome Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Innate Pharma
11.1.1 Innate Pharma Company Detail
11.1.2 Innate Pharma Business Overview
11.1.3 Innate Pharma Sezary Syndrome Treatment Introduction
11.1.4 Innate Pharma Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.1.5 Innate Pharma Recent Development
11.2 Kyowa Kirin
11.2.1 Kyowa Kirin Company Detail
11.2.2 Kyowa Kirin Business Overview
11.2.3 Kyowa Kirin Sezary Syndrome Treatment Introduction
11.2.4 Kyowa Kirin Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.2.5 Kyowa Kirin Recent Development
11.3 Shionogi
11.3.1 Shionogi Company Detail
11.3.2 Shionogi Business Overview
11.3.3 Shionogi Sezary Syndrome Treatment Introduction
11.3.4 Shionogi Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.3.5 Shionogi Recent Development
11.4 Bioniz Therapeutics
11.4.1 Bioniz Therapeutics Company Detail
11.4.2 Bioniz Therapeutics Business Overview
11.4.3 Bioniz Therapeutics Sezary Syndrome Treatment Introduction
11.4.4 Bioniz Therapeutics Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.4.5 Bioniz Therapeutics Recent Development
11.5 Eisai
11.5.1 Eisai Company Detail
11.5.2 Eisai Business Overview
11.5.3 Eisai Sezary Syndrome Treatment Introduction
11.5.4 Eisai Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.5.5 Eisai Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Sezary Syndrome Treatment Introduction
11.6.4 Bayer Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.6.5 Bayer Recent Development
11.7 Minophagen Pharmaceutical Co., Ltd
11.7.1 Minophagen Pharmaceutical Co., Ltd Company Detail
11.7.2 Minophagen Pharmaceutical Co., Ltd Business Overview
11.7.3 Minophagen Pharmaceutical Co., Ltd Sezary Syndrome Treatment Introduction
11.7.4 Minophagen Pharmaceutical Co., Ltd Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.7.5 Minophagen Pharmaceutical Co., Ltd Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Sezary Syndrome Treatment Introduction
11.8.4 Novartis Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 STI Pharma
11.9.1 STI Pharma Company Detail
11.9.2 STI Pharma Business Overview
11.9.3 STI Pharma Sezary Syndrome Treatment Introduction
11.9.4 STI Pharma Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.9.5 STI Pharma Recent Development
11.10 Gilead
11.10.1 Gilead Company Detail
11.10.2 Gilead Business Overview
11.10.3 Gilead Sezary Syndrome Treatment Introduction
11.10.4 Gilead Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.10.5 Gilead Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Sezary Syndrome Treatment Introduction
11.11.4 Merck Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.11.5 Merck Recent Development
11.12 Hikma
11.12.1 Hikma Company Detail
11.12.2 Hikma Business Overview
11.12.3 Hikma Sezary Syndrome Treatment Introduction
11.12.4 Hikma Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.12.5 Hikma Recent Development
11.13 Seattle Genetics
11.13.1 Seattle Genetics Company Detail
11.13.2 Seattle Genetics Business Overview
11.13.3 Seattle Genetics Sezary Syndrome Treatment Introduction
11.13.4 Seattle Genetics Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.13.5 Seattle Genetics Recent Development
11.14 Amerigen Pharmaceuticals
11.14.1 Amerigen Pharmaceuticals Company Detail
11.14.2 Amerigen Pharmaceuticals Business Overview
11.14.3 Amerigen Pharmaceuticals Sezary Syndrome Treatment Introduction
11.14.4 Amerigen Pharmaceuticals Revenue in Sezary Syndrome Treatment Business (2018-2023)
11.14.5 Amerigen Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Sezary Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Radiation therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Extracorporeal Photochemotherapy
Table 6. Global Sezary Syndrome Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Sezary Syndrome Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Sezary Syndrome Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Sezary Syndrome Treatment Market Share by Region (2018-2023)
Table 10. Global Sezary Syndrome Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Sezary Syndrome Treatment Market Share by Region (2024-2029)
Table 12. Sezary Syndrome Treatment Market Trends
Table 13. Sezary Syndrome Treatment Market Drivers
Table 14. Sezary Syndrome Treatment Market Challenges
Table 15. Sezary Syndrome Treatment Market Restraints
Table 16. Global Sezary Syndrome Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Sezary Syndrome Treatment Market Share by Players (2018-2023)
Table 18. Global Top Sezary Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sezary Syndrome Treatment as of 2022)
Table 19. Ranking of Global Top Sezary Syndrome Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Sezary Syndrome Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Sezary Syndrome Treatment Product Solution and Service
Table 23. Date of Enter into Sezary Syndrome Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Sezary Syndrome Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Sezary Syndrome Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Sezary Syndrome Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Sezary Syndrome Treatment Revenue Market Share by Type (2024-2029)
Table 29. Global Sezary Syndrome Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Sezary Syndrome Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Sezary Syndrome Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Sezary Syndrome Treatment Revenue Market Share by Application (2024-2029)
Table 33. North America Sezary Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Sezary Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Sezary Syndrome Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Sezary Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Sezary Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Sezary Syndrome Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Sezary Syndrome Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Sezary Syndrome Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Sezary Syndrome Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Sezary Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Sezary Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Sezary Syndrome Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Sezary Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Sezary Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Sezary Syndrome Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 48. Innate Pharma Company Detail
Table 49. Innate Pharma Business Overview
Table 50. Innate Pharma Sezary Syndrome Treatment Product
Table 51. Innate Pharma Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 52. Innate Pharma Recent Development
Table 53. Kyowa Kirin Company Detail
Table 54. Kyowa Kirin Business Overview
Table 55. Kyowa Kirin Sezary Syndrome Treatment Product
Table 56. Kyowa Kirin Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 57. Kyowa Kirin Recent Development
Table 58. Shionogi Company Detail
Table 59. Shionogi Business Overview
Table 60. Shionogi Sezary Syndrome Treatment Product
Table 61. Shionogi Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 62. Shionogi Recent Development
Table 63. Bioniz Therapeutics Company Detail
Table 64. Bioniz Therapeutics Business Overview
Table 65. Bioniz Therapeutics Sezary Syndrome Treatment Product
Table 66. Bioniz Therapeutics Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 67. Bioniz Therapeutics Recent Development
Table 68. Eisai Company Detail
Table 69. Eisai Business Overview
Table 70. Eisai Sezary Syndrome Treatment Product
Table 71. Eisai Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 72. Eisai Recent Development
Table 73. Bayer Company Detail
Table 74. Bayer Business Overview
Table 75. Bayer Sezary Syndrome Treatment Product
Table 76. Bayer Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 77. Bayer Recent Development
Table 78. Minophagen Pharmaceutical Co., Ltd Company Detail
Table 79. Minophagen Pharmaceutical Co., Ltd Business Overview
Table 80. Minophagen Pharmaceutical Co., Ltd Sezary Syndrome Treatment Product
Table 81. Minophagen Pharmaceutical Co., Ltd Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 82. Minophagen Pharmaceutical Co., Ltd Recent Development
Table 83. Novartis Company Detail
Table 84. Novartis Business Overview
Table 85. Novartis Sezary Syndrome Treatment Product
Table 86. Novartis Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. STI Pharma Company Detail
Table 89. STI Pharma Business Overview
Table 90. STI Pharma Sezary Syndrome Treatment Product
Table 91. STI Pharma Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 92. STI Pharma Recent Development
Table 93. Gilead Company Detail
Table 94. Gilead Business Overview
Table 95. Gilead Sezary Syndrome Treatment Product
Table 96. Gilead Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 97. Gilead Recent Development
Table 98. Merck Company Detail
Table 99. Merck Business Overview
Table 100. Merck Sezary Syndrome Treatment Product
Table 101. Merck Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 102. Merck Recent Development
Table 103. Hikma Company Detail
Table 104. Hikma Business Overview
Table 105. Hikma Sezary Syndrome Treatment Product
Table 106. Hikma Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 107. Hikma Recent Development
Table 108. Seattle Genetics Company Detail
Table 109. Seattle Genetics Business Overview
Table 110. Seattle Genetics Sezary Syndrome Treatment Product
Table 111. Seattle Genetics Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 112. Seattle Genetics Recent Development
Table 113. Amerigen Pharmaceuticals Company Detail
Table 114. Amerigen Pharmaceuticals Business Overview
Table 115. Amerigen Pharmaceuticals Sezary Syndrome Treatment Product
Table 116. Amerigen Pharmaceuticals Revenue in Sezary Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 117. Amerigen Pharmaceuticals Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sezary Syndrome Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Sezary Syndrome Treatment Market Share by Type: 2022 VS 2029
Figure 3. Radiation therapy Features
Figure 4. Chemotherapy Features
Figure 5. Immunotherapy Features
Figure 6. Extracorporeal Photochemotherapy Features
Figure 7. Global Sezary Syndrome Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Sezary Syndrome Treatment Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Specialist Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Sezary Syndrome Treatment Report Years Considered
Figure 13. Global Sezary Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Sezary Syndrome Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Sezary Syndrome Treatment Market Share by Region: 2022 VS 2029
Figure 16. Global Sezary Syndrome Treatment Market Share by Players in 2022
Figure 17. Global Top Sezary Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sezary Syndrome Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Sezary Syndrome Treatment Revenue in 2022
Figure 19. North America Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Sezary Syndrome Treatment Market Share by Country (2018-2029)
Figure 21. United States Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Sezary Syndrome Treatment Market Share by Country (2018-2029)
Figure 25. Germany Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Sezary Syndrome Treatment Market Share by Region (2018-2029)
Figure 33. China Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Sezary Syndrome Treatment Market Share by Country (2018-2029)
Figure 41. Mexico Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Sezary Syndrome Treatment Market Share by Country (2018-2029)
Figure 45. Turkey Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Sezary Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Innate Pharma Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 48. Kyowa Kirin Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 49. Shionogi Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 50. Bioniz Therapeutics Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 51. Eisai Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 52. Bayer Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 53. Minophagen Pharmaceutical Co., Ltd Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 55. STI Pharma Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 56. Gilead Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 57. Merck Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 58. Hikma Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 59. Seattle Genetics Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 60. Amerigen Pharmaceuticals Revenue Growth Rate in Sezary Syndrome Treatment Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 黄体形成ホルモン放出拮抗薬のグローバル市場展望 2023年-2029年：ホルモン療法、免疫療法、標的療法、化学療法、その他
  • 膵臓がん転移治療の世界市場2023年：化学療法、標的療法、その他
  • ネザートン症候群治療の世界市場2023年：放射線治療、生物治療、その他
  • コウニス症候群治療の世界市場2023年：β-ラクタム系抗生物質、非ステロイド性抗炎症薬、ロクロニウム、その他
  • 家族性カイロミクロン血症症候群治療薬の世界市場2023年：健康補助食品家族性カイロミクロン血症治療剤、遺伝子治療剤家族性カイロミクロン血症治療剤
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA6930 )"セザリー症候群治療の世界市場2023年：放射線療法、化学療法、免疫療法、体外光化学療法" (英文：Global Sezary Syndrome Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。